Purpose

This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.

Conditions

Eligibility

Eligible Ages
Over 50 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Aged 50 years and older - At least 8th grade education

Exclusion Criteria

  • Diagnosed type 1 or type 2 diabetes - Current use of mediation for diabetes (oral hypoglycemic agents, insulin), or with diabetic properties (e.g., steroids) - Chronic disorders (cardiovascular disease, peripheral vascular disease, stroke, transient ischemic attack, chronic kidney disease, past year cancer) - Neurological disorders (e.g., Parkinson's, epilepsy, multiple sclerosis) - History of dementia or suspected dementia - Known HIV - Serious mental illness, psychosis, or use of psychotropic medication - Heavy alcohol use

Study Design

Phase
Study Type
Observational
Observational Model
Ecologic or Community
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
Middle-aged and Older adults with Prediabetes Middle-aged and Older adults with Prediabetes
  • Device: Continuous Glucose Monitoring System (CGMS)
    Continuous Glucose Monitoring System (CGMS)- minimally invasive sensors that measure glucose concentrations at 5-min intervals over several days.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
University of Maryland, Baltimore

Study Contact

Kathleen Simpson
4106057179
Kathleen.Simpson@va.gov

Detailed Description

Type 2 diabetes (T2DM) is now widely considered a major public health epidemic. T2DM is highly prevalent worldwide, is among the leading causes of death, and is an independent risk factor for dementia and less severe forms of cognitive dysfunction. The investigators are utilizing novel technology to understand the role of variability in glucose on neurocognition and functional status among middle-aged and older adults at risk for diabetes. The central hypothesis is that even before diabetes onset, variability in glucose will be associated with worse cognitive function and lower functional status. Participants will be asked to wear a glucose monitoring device over a 10-day period in their home environment. Assessment of functional status and neurocognitive function, in addition to sociodemographic factors, health habits and mood will also occur over two study visits.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.